NLRP3 and neuropathy: Accordingly, inhibition of the IL‐1 receptor using anakinra or the NLRP3 inflammasome using the small molecule NLRP3 inhibitor MCC950 prevented sensory–motor neuropathy following vincristine monotherapy in mice.9